Nanobiotix S.A. Nonderivative Financial Liabilities Undiscounted Cash Flows
Nanobiotix S.A. (NNBXF) had Nonderivative Financial Liabilities Undiscounted Cash Flows of EUR 344.09 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2026-03-31
- 2025-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 344.09M EUR.
- 2025-06-30: Nonderivative Financial Liabilities Undiscounted Cash Flows 105.82M EUR.
- 2024-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 111.04M EUR.
- 2024-06-30: Nonderivative Financial Liabilities Undiscounted Cash Flows 112.85M EUR.
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2025-12-31 | 344.09M EUR 20-F · filed 2026-03-31 |
| 2025-06-30 | 105.82M EUR 6-K · filed 2025-09-30 |
| 2024-12-31 | 111.04M EUR 20-F · filed 2026-03-31 |
| 2024-06-30 | 112.85M EUR 6-K · filed 2024-09-18 |
| 2023-12-31 | 104.61M EUR 6-K · filed 2024-09-18 |
| 2023-06-30 | 76.06M EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 76.56M EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 51.36M EUR 6-K · filed 2022-09-28 |
| 2021-06-30 | 57.17M EUR 6-K · filed 2021-09-08 |